Supplements touting CV benefits may be ‘harmful distraction’ from proven solutions healio.com/news/cardiolog… #CardioTwitter #Cardiology Dr. Deepak L. Bhatt Luke J. Laffin Pam R. Taub, MD❤️💃🏻 Brigham and Women's Hospital Mass General Brigham Mount Sinai Fuster Heart Hospital Cleveland Clinic Heart, Vascular & Thoracic ClevelandClinicNews UC San Diego Health Icahn School of Medicine at Mount Sinai

We had Luke J. Laffin on the DocsWhoLift Podcast to discuss his recent statin vs. supplement study among other things (saunas and mortality). Take a listen! Karl Nadolsky podcasters.spotify.com/pod/show/docsw…

The lipid-lowering drug’s treatment effect was greater in this prespecified analysis of high-risk patients without a prior cardiac event than in the overall trial’s secondary prevention cohort. Luke J. Laffin CCF Cardiology Fellows consultqd.clevelandclinic.org/clear-outcomes…

In this randomized clinical trial, lorundrostat decreased blood pressure significantly more than placebo with 50-mg and 100-mg once-daily doses, and adverse events, including hyperkalemia, were uncommon. ja.ma/3Ex1tHS #Hypertension23

Great to present data from TargetHTN trial of lorundrostat for treatment of uncontrolled hypertension AHAMeetings with #simpub in JAMA . jamanetwork.com/journals/jama/… Thanks to co-authors, 𝙼𝚊𝚝𝚝 𝙻𝚞𝚝𝚑𝚎𝚛 Anand Vaidya #Hypertension23 Cleveland Clinic ClevelandClinicNews

#Lorundrostat was associated with clinically significant reductions in automated office BP for people with uncontrolled hypertension, with the greatest effects seen in people with concomitant obesity Luke J. Laffin Cleveland Clinic MD Endocrine Today healio.com/news/cardiolog…

"We need all the tools we can get to treat hypertension to the target," Wanpen Vongpatanasin told TCTMD; study by Luke J. Laffin et al #Hypertension23 AHA Science tctmd.com/news/lorundros…

Honored to present our work on AI and Hypertension Guidelines at American Heart Association Hypertension 2023 to an amazing audience and co-presenters. Serge C. Harb Samir Kapadia Cleveland Clinic Heart, Vascular & Thoracic Luke J. Laffin Hypertension Press release below 👇🏻 professional.heart.org/en/meetings/hy…

Telehealth-based delivery of cardiac rehabilitation is not yet a pragmatic option for many Medicare beneficiaries, a Cleveland Clinic study finds. The results raise questions about progress toward national cardiac rehab participation goals. Luke J. Laffin consultqd.clevelandclinic.org/lack-of-broadb…

#BreakingNews: We’ve received FDA approval for the Paradise™ Ultrasound Renal Denervation (#RDN) system – making it the FIRST US-approved RDN system to treat hypertension. 🙌 bit.ly/3sxNMpw Important Safety Information: bit.ly/473Nhm7

🚨Attention all CardioNerds !! Join #HouseTaussig 🫀and a panel of phenomenal experts tomorrow at 8:00 PM EST to discuss the revolutionary results of #SELECT 🔥 An absolute gamechanger!🤩 Can't wait to see you then! 🕗

Congratulations to Dr. George Bakris UChicago Medicine Dr Luke J. Laffin Cleveland Clinic MD and Dr. Matthew Sorrentino UChicago Medicine on the publication of #Hypertension 4e: A Companion to Braunwald's Heart Disease bit.ly/3Sx2jMp Elsevier for Medical Professionals

Glad to be coauthor with Luke J. Laffin and James deLemos in a research highlighting the role of GLP1RA on 24 hABP in SURMOUNT-1 UTSW Heart Hypertension ahajournals.org/doi/10.1161/HY…

Engaging Cleveland Clinic satellite symposium MDVIP’s National Meeting this weekend, on current state-of-the-art practices & emerging therapies in CVD risk reduction🫀 Thanks to all who joined us! Luke J. Laffin Ashish Sarraju CCF Cardiology Fellows

Great to have you work with Cleveland Clinic Heart, Vascular & Thoracic . Best of luck!

We have an opportunity for a staff position in the Clinical Section at the Cleveland Clinic. This section houses experts in ACHD, cardio oncology, sports cardiology, critical care, and general cardiology who are outstanding clinicians with a passion for edu/research Samir Kapadia

🗣️ In our 3-part #HealioExclusive, we discuss: 🔑The cardiometabolic consequences of obesity 🔑Emerging data on BP after weight loss 🔑Benefits of an obesity-first treatment strategy 📰Read part 1 here! healio.com/news/cardiolog… MS Center for Clinical and Translational Research Cleveland Clinic MD Luke J. Laffin Endocrine Today

George L Bakris Memorial Symposium on hypertension is around the corner ! It's a great opportunity to connect with the experts in the field. Please join us on Sep 12th Both in person and virtual options available: 6thannualrenalresearchret.rsvpify.com